# Roche completes acquisition of TIB Molbiol

Roche completed the acquisition of 100% of TIB Molbiol Group, a developer of PCR assays for emerging infectious diseases. TIB Molbiol will operate as a subsidiary within Roche Diagnostics.

- Type: Acquisition
- Announced: 2021-12-01
- Where: Germany
- Status: completed
- Products: PCR assays for infectious diseases
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Roche Holdings Inc](https://endata.com/companies/16415.md) (acquirer)
- [TIB Molbiol](https://endata.com/companies/59339.md) (target)

## Sources

- [roche.com](https://www.roche.com/media/releases/med-cor-2021-12-01), 2021-12-01: "Roche today announced it has completed its share purchase agreement to acquire 100 percent of the outstanding shares of TIB Molbiol Group."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.